- Home
- BPOP vs CORT Comparison
BPOP vs CORT Comparison
Compare BPOP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOP
- CORT
- Stock Information
- Founded
- BPOP 1893
- CORT 1998
- Country
- BPOP United States
- CORT United States
- Employees
- BPOP N/A
- CORT N/A
- Industry
- BPOP Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BPOP Finance
- CORT Health Care
- Exchange
- BPOP Nasdaq
- CORT Nasdaq
- Market Cap
- BPOP 7.8B
- CORT 8.8B
- IPO Year
- BPOP N/A
- CORT N/A
- Fundamental
- Price
- BPOP $125.64
- CORT $89.51
- Analyst Decision
- BPOP Buy
- CORT Strong Buy
- Analyst Count
- BPOP 7
- CORT 4
- Target Price
- BPOP $128.71
- CORT $139.00
- AVG Volume (30 Days)
- BPOP 514.2K
- CORT 917.9K
- Earning Date
- BPOP 10-23-2025
- CORT 10-29-2025
- Dividend Yield
- BPOP 2.39%
- CORT N/A
- EPS Growth
- BPOP 44.82
- CORT N/A
- EPS
- BPOP 10.29
- CORT 1.11
- Revenue
- BPOP $2,799,129,000.00
- CORT $716,080,000.00
- Revenue This Year
- BPOP $0.07
- CORT $30.77
- Revenue Next Year
- BPOP $7.45
- CORT $37.75
- P/E Ratio
- BPOP $12.22
- CORT $81.04
- Revenue Growth
- BPOP 8.02
- CORT 25.71
- 52 Week Low
- BPOP $78.23
- CORT $42.01
- 52 Week High
- BPOP $129.32
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BPOP 52.87
- CORT 77.49
- Support Level
- BPOP $123.69
- CORT $82.70
- Resistance Level
- BPOP $129.10
- CORT $90.71
- Average True Range (ATR)
- BPOP 2.51
- CORT 2.60
- MACD
- BPOP -0.52
- CORT 0.78
- Stochastic Oscillator
- BPOP 29.31
- CORT 94.53
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.